Copeland Capital Management LLC lessened its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 6.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 786,114 shares of the company's stock after selling 57,867 shares during the period. U.S. Physical Therapy makes up 1.4% of Copeland Capital Management LLC's investment portfolio, making the stock its 19th largest holding. Copeland Capital Management LLC owned 5.17% of U.S. Physical Therapy worth $61,388,000 at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in USPH. William Blair Investment Management LLC acquired a new stake in shares of U.S. Physical Therapy in the 3rd quarter worth $29,381,000. American Century Companies Inc. acquired a new stake in shares of U.S. Physical Therapy in the 3rd quarter worth $21,940,000. Bahl & Gaynor Inc. lifted its stake in shares of U.S. Physical Therapy by 47.6% in the 3rd quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company's stock worth $40,325,000 after acquiring an additional 153,054 shares during the period. Bank of America Corp DE lifted its stake in shares of U.S. Physical Therapy by 77.2% in the 3rd quarter. Bank of America Corp DE now owns 317,200 shares of the company's stock worth $26,946,000 after acquiring an additional 138,194 shares during the period. Finally, 4D Advisors LLC acquired a new stake in shares of U.S. Physical Therapy in the 3rd quarter worth $9,344,000.
U.S. Physical Therapy Stock Performance
Shares of USPH opened at $74.91 on Friday. The company has a 50-day simple moving average of $78.59 and a 200-day simple moving average of $80.72. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $1.13 billion, a PE ratio of 52.75, a P/E/G ratio of 2.00 and a beta of 1.35. U.S. Physical Therapy, Inc. has a 52-week low of $66.67 and a 52-week high of $93.50.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported $0.67 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.67. The business had revenue of $202.73 million during the quarter, compared to the consensus estimate of $200.10 million. U.S. Physical Therapy had a net margin of 5.07% and a return on equity of 8.75%. The business's revenue was up 12.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.51 EPS. Equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.87 earnings per share for the current fiscal year.
U.S. Physical Therapy Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, April 10th. Stockholders of record on Friday, March 13th were issued a $0.46 dividend. The ex-dividend date was Friday, March 13th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.5%. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.45. U.S. Physical Therapy's payout ratio is 129.58%.
Insider Transactions at U.S. Physical Therapy
In other news, COO Graham D. Reeve sold 662 shares of the stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $78.86, for a total value of $52,205.32. Following the completion of the transaction, the chief operating officer owned 30,078 shares in the company, valued at $2,371,951.08. This trade represents a 2.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Richard Binstein sold 3,000 shares of the stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $81.64, for a total transaction of $244,920.00. Following the completion of the transaction, the executive vice president owned 24,867 shares of the company's stock, valued at $2,030,141.88. This represents a 10.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 2.00% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the stock. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a "strong-buy" rating in a research note on Thursday, March 12th. Barrington Research restated an "outperform" rating and issued a $103.00 target price on shares of U.S. Physical Therapy in a research note on Friday, February 20th. Finally, Weiss Ratings restated a "hold (c)" rating on shares of U.S. Physical Therapy in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, U.S. Physical Therapy presently has a consensus rating of "Moderate Buy" and an average price target of $101.67.
Check Out Our Latest Analysis on USPH
U.S. Physical Therapy Profile
(
Free Report)
U.S. Physical Therapy, Inc NYSE: USPH is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Featured Stories
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report